某医药企业于 “新三板”顺利挂牌
XX Medicine Enterprise Has Successfully Listed on “New Three Board”
随着一声清脆的开市钟声响起，XX医药股份有限公司正式开启了资本市场的新航程！
Along with a clear ring for market opening, XX Pharmaceutical Co., Ltd officially launches the new attempt in capital market.
公司目前拥有全球最大盐酸金刚烷胺的生产基地，能够同时满足为德国BASF、美国SACHEM、中节能万润等国内外行业巨头公司提供高品质、高效益的产品。
At present, the company possesses the world’s largest production base of amantadine hydrochloride and could simultaneously provide high-quality and high-benefit products for domestic and overseas industry magnates such as BASF in Germany and SACHEM in America and CECEP Valiant, etc.
金刚烷、盐酸金刚烷胺及其他金刚烷衍生物，广泛应用于抗病毒类药物以及糖尿病药物生产之中，市场潜力巨大。现阶段，公司为国内外巨头提供列汀糖尿病类药医药中间体。同时，也已加速列汀类制剂的研发申报工作。
With a huge market potential, adamantane, amantadine hydrochloride and other amantadine derivatives are widely used in the production of antiviral drugs and diabetes drugs. At the present stage, the company supplies medical intermediate of Statins diabetes drugs for domestic and overseas industry magnates. At the same time, the company accelerates the research and development and declaration of Statins preparations.
盐酸金刚烷胺除应用于医药领域之外，还是汽车尾气处理技术（DPF）中的核心——高分子聚合物的主要原料之一。
Except for the application in medicine, amantadine hydrochloride is one of the main raw materials of macromolecular polymer that can be regarded as the core in Diesel Particulate Filter (DPF).
随着全球汽车尾气执行标准不断提升，环保材料的研发与使用形成了新的、巨大的生产力。相比较传统材料，含金刚烷的高分子聚合物的吸附效率更高，综合成本更优，必将成为新一代汽车尾气处理发展的重要原材料。
With the continuous improvement of executive standards for global automobile exhaust, the research and development and use of environmental protection materials form the new and huge productivity. Compared with traditional materials, macromolecular polymer containing adamantine possesses higher absorption efficiency and optimized comprehensive costs which means that they would inevitably become the important materials for exhaust disposal evolution of new generation automobile.
综观XX医药十年的发展与沉淀，企业以坚实严谨的科研实力、系统完备的产业基础、品质优良的系列产品，一直深受合作友商的尊重与认可，为国内行业发展做出很大贡献，赢得社会各界的赞誉与口碑，未来市场前景不可限量。
Throughout the ten years of development and sedimentation of XX Medicine; it’s believed that the enterprise is deeply subjected to the respects and acceptance of cooperative partners all the time, makes great contribution to domestic industrial development, and wins the compliments and praise from all walks of life with our solid and rigorous scientific research strength, complete system basis for industry and high quality series products, which endows the company with unlimited market prospect.
在以董事长为核心的领导团队的带领之下，XX医药将以“新三板”登陆为新起点，秉承一贯的“存仁心，通儒道”的文化理念，在医药、化工两大领域精耕细作，以科技创新带动发展，用专业品质和高效服务奠定长青基业。
Guided by the leading team in which chairman is the core factor; XX medicine would take listing on “New Three Board” as a new start, adhere to the uniform cultural concept of “being benevolent and pursuing of the Confucianism”, intensively aim at these two fields of medicine and chemical engineering, boost the development with scientific and technological innovation and maintain an everlasting career with professional quality and efficient services.
